Klisyri
Klisyri is a medicine authorised by Swissmedic under authorisation number 68322. The authorisation holder is Almirall AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 February 2022 and the authorisation is valid without a time limit. ATC code D06BX03 places the medicine in the group Antibiotics and chemotherapeutics for dermatological use.
| Authorisation number | 68322 |
|---|---|
| Name | Klisyri |
| Full name | Klisyri, Salbe |
| Authorisation holder | Almirall AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | D06BX03 |
| First authorisation | 03 February 2022 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Klisyri, Salbe | A | 03 February 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | Beutel | D06BX03 | 07.16.4. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Klisyri authorised in Switzerland?
Yes. Klisyri is authorised by Swissmedic under authorisation number 68322, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Klisyri have?
Klisyri is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Klisyri?
The authorisation holder is Almirall AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.